The N-of-1 Trial: Implications for Biologic Therapies in Psoriasis
A new strategy that is designed to improve on the "stepped care" approach compares therapies in individual patients.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Activate your free online account for full access to all site content and features.
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)